Volume | 64,937 |
|
|||||
News | - | ||||||
Day High | 2.74 | Low High |
|||||
Day Low | 2.68 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.74 | 2.68 | 2.74 | 2.74 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
593 | 64,937 | $ 2.71 | $ 175,837 | - | 1.69 - 3.29 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
10:44:21 | 11 | $ 2.705 | USD |
Arbutus Biopharma Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
484.63M | 179.49M | - | 18.14M | -72.85M | -0.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arbutus Biopharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABUS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.78 | 2.81 | 2.635 | 2.72 | 824,256 | -0.07 | -2.52% |
1 Month | 2.59 | 3.29 | 2.30 | 2.94 | 2,193,323 | 0.12 | 4.63% |
3 Months | 2.40 | 3.29 | 2.265 | 2.83 | 1,446,339 | 0.31 | 12.92% |
6 Months | 1.82 | 3.29 | 1.70 | 2.58 | 1,057,516 | 0.89 | 48.90% |
1 Year | 2.62 | 3.29 | 1.69 | 2.44 | 841,612 | 0.09 | 3.44% |
3 Years | 3.23 | 6.50 | 1.69 | 3.50 | 1,938,247 | -0.52 | -16.10% |
5 Years | 2.75 | 9.00 | 0.81 | 3.66 | 2,062,469 | -0.04 | -1.45% |
Arbutus Biopharma Description
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. |